ZLAB
Zai Lab (ZLAB)
$34
About Zai Lab (ZLAB)
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Details
Daily high
$17.72
Daily low
$17.25
Price at open
$17.68
52 Week High
$44.34
52 Week Low
$17.25
Market cap
1.9B
Dividend yield
0.00%
Volume
723,818
Avg. volume
868,012
P/E ratio
-8.90
Zai Lab News
Details
Daily high
$17.72
Daily low
$17.25
Price at open
$17.68
52 Week High
$44.34
52 Week Low
$17.25
Market cap
1.9B
Dividend yield
0.00%
Volume
723,818
Avg. volume
868,012
P/E ratio
-8.90